VIM and chronic obstructive pulmonary disease: Future investigations should be aimed at assessing the differential expression of p63 and vimentin in patients with normal lung function (as measured by FEV1 and FEV1/FVC) and imaging patterns of emphysema, potentially indicating a specific COPD phenotype.